ECCMID 2023

Join us at our booth where we’ll showcase our revolutionary MALDI Biotyper^® sirius IVD System, now offering lightning-fast analysis for routine microbial identification. Our market-leading MALDI-TOF is now equipped with a new zero-button IDealTune^™ feature securing optimal performance without extra cost or effort. Additionally, the system’s analytical power has been expanded to deal with identification of 222 filamentous fungi species/ species groups, with a stunningly easy Mycelium Transfer (MyT) sample preparation procedure, ensuring high analysis success rates.

You'll also witness the power of our complementary and interrelated IR Biotyper^®, providing quick and easy microbial strain typing for hospital hygiene, enabling preventive epidemiology. The built‐in classifiers facilitate quick decision‐making.

That's not all - discover our extensive Molecular Diagnostics portfolio, featuring the integrated workflow of the FluoroType^® approach, assays for the detection of various diseases, and the game-changing LiquidArray^® technology powering next‐generation multiplexing in a familiar PCR‐based workflow.

And finally, discover our UMIC^® product line for single drug MIC testing based on broth microdilution, focused on last-resort antibiotics, including UMIC^® Cefiderocol.

On our booth you can also to talk to our NMR-colleague to learn about PhenoRisk PACS^™ RuO, a multi-organ phenomic risk screening for research in post-acute COVID syndrome.

Don't miss out on this opportunity to see the future of diagnostics - see you at our booth!

This Integrated Symposium highlights the latest updates and trends across a broad spectrum of technologies, including microbial identification, strain and vector typing, molecular and rapid AST assays.
The use of AI approaches on large MALDI‐TOF datasets from microbial identification opens new possibilities in research and future diagnostics, already being explored by MALDI-TOF users.
IR spectroscopy strain typing technology greatly facilitates hygiene control and epidemiology as the built‐in classifiers enable quick decision‐making.
Infectious disease molecular diagnostic assays provide comprehensive coverage with powerful next‐generation multiplexing in a familiar PCR‐based workflow.
Join our symposium to learn how our endeavor to changing microbiology through revolutionary technologies aims at enhancing today's diagnostics!

Chairs:
Dr. Stefan Zimmermann, Universitätsklinikum Heidelberg, Heidelberg, Germany
Dr. Onya Opota, University of Lausanne, Institute of Microbiology, Lausanne, Switzerland

4:15-4:25 Welcome

4:25-4:50 New achievements in the identification of yeasts and filamentous fungi by MALDI-TOF MS
Dr. Sandra Gräber, Klinikum Oldenburg, Oldenburg, Germany

4:50-5:15 MALDI-TOF MS for surveillance of malaria vectors
Dr. Marta Maia, KEMRI Wellcome Trust, Kilifi, Kenya

5:15-5:40 Can the routine use of FTIR spectroscopy help to improve the control and prevention of healthcare associated infections?
Dr. Crespin C. Adjidé, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France

5:40-6:05 Advances and perspectives in infection diagnostics and control
Dr. Markus Kostrzewa, Bruker Microbiology & Infection Diagnostics, Germany

6:05-6:15 Panel Discussion and Q&A

Take a look on our poster list, covering a broad range of scientific and diagnostic topics that Bruker Microbiology & Infection Diagnostics and its cooperation partners have recently worked on.